ANRO · Alto Neuroscience Inc. Common Stock
View on chartInsiders & Stakes
| Alpha Wave Global, LP 10% Owner | ▲ Buy | Open Market | 3,707,757 Shares held | 2/6/2024 | View profile |
| Amit Etkin PRESIDENT AND CEO | ▼ Sell | Gift | 833,949 Shares held | 5/14/2026 | View profile |
| Cox Christopher Nixon | ▼ Sell | Other | 715,653 Shares held | 2/6/2024 | View profile |
| Apeiron Investment Group Ltd. 10% Owner | ▼ Sell | Other | 674,658 Shares held | 2/6/2024 | View profile |
| Nicholas Conrad Smith PRESIDENT AND CFO | ▲ Buy | Option Exercise | 79,060 Shares held | 10/2/2026 | View profile |
| Chen Po Yu (Jeff) | ▼ Sell | Other | 47,709 Shares held | 2/6/2024 | View profile |
| Adam Savitz CHIEF MEDICAL OFFICER | ▲ Buy | Open Market | 39,851 Shares held | 7/10/2024 | View profile |
| York Gwill | ▼ Sell | Other | 23,917 Shares held | 2/6/2024 | View profile |
Transaction History
| Nicholas Conrad Smith | ▲ Buy | Option Exercise | 55,000 | $128K | 10/2/2026 |
| Nicholas Conrad Smith | ▲ Buy | Option Exercise | 24,056 | $57K | 9/30/2026 |
| Nicholas Conrad Smith | ▼ Sell | Open Market | 23,170 | $597K | 9/30/2026 |
| Nicholas Conrad Smith | ▼ Sell | Open Market | 886 | $24K | 9/30/2026 |
| Nicholas Conrad Smith | ▲ Buy | Option Exercise | 56,455 | $133K | 9/29/2026 |
| Nicholas Conrad Smith | ▲ Buy | Option Exercise | 54,375 | $128K | 9/29/2026 |
| Nicholas Conrad Smith | ▼ Sell | Open Market | 110,830 | $2.9M | 9/29/2026 |
| Amit Etkin | ▼ Sell | Gift | 400,000 | $0 | 5/14/2026 |
| Amit Etkin | ▼ Sell | Tax Withholding | 6,227 | $123K | 3/1/2026 |
| Nicholas Conrad Smith | ▼ Sell | Tax Withholding | 2,806 | $55K | 3/1/2026 |
| Adam Savitz | ▲ Buy | Open Market | 2,931 | $39K | 7/10/2024 |
| Adam Savitz | ▲ Buy | Open Market | 10,681 | $134K | 7/9/2024 |
| Adam Savitz | ▲ Buy | Open Market | 1,388 | $18K | 7/9/2024 |
| Nicholas Conrad Smith | ▲ Buy | Open Market | 1,600 | $25K | 3/28/2024 |
| Nicholas Conrad Smith | ▲ Buy | Open Market | 4,550 | $75K | 3/28/2024 |
| Nicholas Conrad Smith | ▲ Buy | Grant | 19,153 | $0 | 3/1/2024 |
| Amit Etkin | ▲ Buy | Grant | 34,711 | $0 | 3/1/2024 |
| Alpha Wave Global, LP | ▼ Sell | Other | 1,962,995 | — | 2/6/2024 |
| Alpha Wave Global, LP | ▼ Sell | Other | 1,144,762 | — | 2/6/2024 |
| Alpha Wave Global, LP | ▲ Buy | Open Market | 600,000 | $9.6M | 2/6/2024 |
| York Gwill | ▼ Sell | Other | 23,917 | — | 2/6/2024 |
| Nicholas Conrad Smith | ▲ Buy | Open Market | 1,563 | $25K | 2/6/2024 |
| Cox Christopher Nixon | ▼ Sell | Other | 588,898 | — | 2/6/2024 |
| Cox Christopher Nixon | ▼ Sell | Other | 126,755 | — | 2/6/2024 |
| Adam Savitz | ▼ Sell | Other | 7,851 | — | 2/6/2024 |
| Adam Savitz | ▲ Buy | Open Market | 17,000 | $272K | 2/6/2024 |
| Amit Etkin | ▼ Sell | Other | 11,777 | — | 2/6/2024 |
| Amit Etkin | ▲ Buy | Open Market | 3,125 | $50K | 2/6/2024 |
| Chen Po Yu (Jeff) | ▼ Sell | Other | 39,259 | — | 2/6/2024 |
| Chen Po Yu (Jeff) | ▼ Sell | Other | 8,450 | — | 2/6/2024 |
| Apeiron Investment Group Ltd. | ▼ Sell | Other | 251,881 | — | 2/6/2024 |
| Apeiron Investment Group Ltd. | ▼ Sell | Other | 674,658 | — | 2/6/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
ANRO mentioned in review of lagging medical stocks
A Yahoo article reviewing medical sector performance noted that many medical stocks have lagged behind Cardinal Health this year. Alto Neuroscience, as a medical‑focused company, is part of that broader discussion. The stock is currently near the lower end of its 52‑week range, which aligns with the sector’s weaker momentum.
ANRO mentioned in review of lagging medical stocks. A Yahoo article reviewing medical sector performance noted that many medical stocks have lagged behind Cardinal Health this year. Alto Neuroscience, as a medical‑focused company, is part of that broader discussion. The stock is currently near the lower end of its 52‑week range, which aligns with the sector’s weaker momentum.